Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,226 | 67,988 | 64,182 | 63,333 | 56,060 |
| Marketable Securities | 54,985 | 68,318 | 94,914 | 117,387 | 146,160 |
| Receivables | N/A | 237 | 408 | 306 | 1,182 |
| Inventories | 62 | 58 | 96 | 312 | 303 |
| Other current assets | 458 | 0 | 0 | 0 | 0 |
| TOTAL | $128,797 | $139,915 | $164,310 | $186,706 | $206,815 |
| Non-Current Assets | |||||
| PPE Net | 11,192 | 10,974 | 11,223 | 10,713 | 5,790 |
| Investments And Advances | 50,097 | 57,639 | 54,335 | 60,386 | 62,106 |
| Intangibles | 0 | 643 | 1,566 | 0 | 0 |
| Other Non-Current Assets | 460 | 460 | 521 | 521 | 521 |
| TOTAL | $61,749 | $69,716 | $67,645 | $71,620 | $68,417 |
| Total Assets | $190,546 | $209,631 | $231,955 | $258,326 | $275,232 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,400 | 1,641 | 2,305 | 5,185 | 3,769 |
| Accrued Expenses | 11,261 | 10,952 | 11,571 | 11,481 | 7,090 |
| TOTAL | $13,661 | $12,593 | $14,392 | $17,404 | $11,680 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 516 | 738 | 821 |
| Other Non-Current Liabilities | 0 | 0 | 3,149 | 0 | 0 |
| TOTAL | $4,201 | $4,262 | $4,149 | $1,716 | $1,524 |
| Total Liabilities | $17,862 | $16,855 | $18,541 | $19,120 | $13,204 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,120 | 17,024 | 17,023 | 17,002 | 17,001 |
| Common Shares | 171 | 170 | 170 | 170 | 170 |
| Retained earnings | -241,212 | -214,758 | -188,335 | -166,573 | -142,996 |
| Other shareholders' equity | -6,241 | -7,754 | -9,959 | -7,345 | -4,213 |
| TOTAL | $172,684 | $192,776 | $213,414 | $239,206 | $262,028 |
| Total Liabilities And Equity | $190,546 | $209,631 | $231,955 | $258,326 | $275,232 |